Elizabeth A Gray Selected Research

Vascular Endothelial Growth Factor C

9/2005	Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
3/2005	Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth A Gray Research Topics

Disease

2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2005 - 03/2005
2	Neoplasm Metastasis (Metastasis) 09/2005 - 03/2005
2	Neoplasms (Cancer) 09/2005 - 03/2005
1	Uterine Cervical Dysplasia 09/2005
1	Ovarian Neoplasms (Ovarian Cancer) 09/2005
1	Endometrial Neoplasms (Endometrial Cancer) 09/2005
1	Atypical Squamous Cells of the Cervix 09/2005

Drug/Important Bio-Agent (IBA)

2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2005 - 03/2005
2	Vascular Endothelial Growth Factor CIBA 09/2005 - 03/2005
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 09/2005 - 03/2005
1	Biomarkers (Surrogate Marker)IBA 09/2005
1	Insulin-Like Growth Factor Binding Protein 3IBA 09/2005
1	Vascular Endothelial Growth FactorsIBA 09/2005
1	Bovine Serum AlbuminIBA 03/2005
1	Protein Isoforms (Isoforms)IBA 03/2005
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2005
1	ErbB Receptors (EGF Receptor)IBA 03/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2005
1	Nicotine FDA Link 03/2005
1	Epidermal Growth Factor (EGF)IBA 03/2005

Therapy/Procedure

1	Therapeutics 09/2005
1	Secondary Prevention 09/2005